» Articles » PMID: 38877469

The Levels of Women's Awareness, Experience, Acceptability and Preference for Vaginal Human Papillomavirus (HPV) Self-sampling in Three Provinces of China: a Cross-sectional Study

Overview
Publisher Biomed Central
Date 2024 Jun 14
PMID 38877469
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The primary screening technique for precancerous lesions and cervical cancer is human papillomavirus (HPV) testing, and HPV self-sampling has been shown to be consistent with clinician sampling in terms of the accuracy of the results and may improve cervical cancer screening rates. The aim of this study was to understand the level of awareness, experience, acceptability, and preference for vaginal HPV self-sampling among women in Jiangsu, Zhejiang, and Shanghai, China, and to analyze the possible influencing factors to determine the feasibility of implementing self-sampling.

Methods: Overall, 1793 women were included in the data analysis. A self-administered questionnaire was utilized. In addition to descriptive analysis, univariate and multivariate analyses were used to explore the associations between sociodemographic features, history of cervical cancer screening, and the level of awareness, experience, acceptability, and preference for HPV self-samples.

Results: The participants' level of awareness of and experience with HPV self-sampling were moderate. A total of 88.8% of participants rated the acceptability as "high", and self-sampling was preferred by 64.2% of them for cervical cancer screening. People aged 45 to 54 years showed a preference for both clinician sampling(OR = 1.762 (1.116-2.163)) and self-sampling (OR = 1.823 (1.233-2.697)). Those who had graduated from high school or above (OR = 2.305 (1.517-3.503), OR = 2.432 (1.570-3.768), OR = 3.258 (2.024-5.244)) preferred clinician-sampling, and those with a bachelor's degree or above (OR = 1.664 (1.042-2.657)) preferred self-sampling. Middle- and high-income individuals showed no preference for either sampling method (OR < 1).

Conclusions: HPV self-sampling is widely accepted, but awareness, experience and preferences need to be improved. These results may help to adjust public health strategies for the early inclusion of HPV self-sampling as a screening method in national initiatives to prevent cervical cancer.

Citing Articles

Triage performance of PAX1/JAM3 in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China.

Chen X, Jin X, Kong L, Liou Y, Liu P, Dong Z Clin Epigenetics. 2024; 16(1):108.

PMID: 39152491 PMC: 11330154. DOI: 10.1186/s13148-024-01731-w.

References
1.
Chen X, Qin J, Tang L, Zhang R . [Construction and application of home self-sampling processes for cervical human papillomavirus detection]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021; 55(9):1145-1148. DOI: 10.3760/cma.j.cn112150-20210126-00080. View

2.
The Lancet Public Health . Education: a neglected social determinant of health. Lancet Public Health. 2020; 5(7):e361. PMC: 7326385. DOI: 10.1016/S2468-2667(20)30144-4. View

3.
De Pauw H, Donders G, Weyers S, De Sutter P, Doyen J, Tjalma W . Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study. Arch Public Health. 2021; 79(1):155. PMC: 8403820. DOI: 10.1186/s13690-021-00667-4. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Tsu V, Ginsburg O . The investment case for cervical cancer elimination. Int J Gynaecol Obstet. 2017; 138 Suppl 1:69-73. DOI: 10.1002/ijgo.12193. View